Clinical Advisory Network on Sex and Gender (CAN-SG)
A London private company limited by guarantee, incorporated on 14 June 2023, which runs a network of clinicians campaigning against gender-affirming care for young people and for "single-sex spaces". It describes itself as "a group of clinicians campaigning for clearer dialogue, rigorous science and improved treatment options for gender dysphoria" (1, accessed 2026-11-11). That wording is a frame: the campaign is anti-trans rhetoric, including its appeals to the Cass Review and its attacks on trials and on the World Professional Association for Transgender Health. Its clinicians' credentials do not change that.
Sources: Companies House company and officers pages for 14935232 (2), accessed 2026-11-11; the network's own pages; the Sex Matters page on the network; Transgender Map (an advocacy site, attributed).
Money received
- Companies House: private company limited by guarantee without share capital, "use of 'Limited' exemption", incorporated 2023-06-14, active, SIC code 86900 ("Other human health activities"), registered office London, last accounts made up to 2025-06-30 (next to 2026-06-30, due by 2027-03-31) (Companies House company page, accessed 2026-11-11). No accounts figure is stated.
- It is not on the register of charities of England and Wales, Northern Ireland or Scotland as an entity of that name (Charity Commission for England and Wales, 3; Charity Commission for Northern Ireland, 4; Scottish Charity Regulator, 5). The network's site carries "Donate" and "Donate Support Our Work" links and states no funding sources or amounts (6).
- Micro-entity accounts (iXBRL, Companies House, accessed 2026-11-11), in GBP: period 2023-06-14 to 2024-06-30 (approved 2025-03-03): current assets 1,129, no liabilities, net assets and reserves 1,129; year to 2025-06-30 (approved 2026-03-19): current assets 32,931, net assets and reserves 32,931 (the 2025 filing prints a dash for the prior year instead of the 1,129 of the 2024 filing; figures are given as filed). No income statement is filed, so income is not shown. Employees: none in either year. Two directors signed the 2024 accounts and one director the 2025 accounts (the register lists three current directors and a secretary; not every director signs each filing; by role; the register gives names, but the network's pages do not present them as directors). The network's about page (7, accessed 2026-11-11) names no directors, co-chairs or funders: it lists 13 "members" (under "Some of our members"), among them a psychiatrist and a GP who match the register's two signatories by name only, and Stella O'Malley as a member (a register director of that name ended an appointment on 2023-07-06; the page treats the match as a name match only). No co-chair and no funder is named on any page reviewed here.
Money given
None documented.
People on file
- Register officers (Companies House officers page, accessed 2026-11-11): three directors and a secretary appointed on 2023-06-14 and not resigned (one name appears both as a director and as the secretary, under separate officer IDs; the page does not say it is one person), and one further director, appointed 2023-06-14 and resigned 2023-07-06, whose register name matches that of the profiled psychotherapist Stella O'Malley (account stellaomalley3; see her profile). The network's own members page lists a person of that name, "Psychotherapist, PhD candidate", among thirteen people under "Some of our members include" and gives no role beyond membership (6). The register gives a name only; Transgender Map, an advocacy site that cites no separate source, lists the appointment as hers and lists her as one of four speakers at the network's webinar "Introducing the Clinical Advisory Network on Sex & Gender" of 11 October 2023. No page of the network states that she was a director, so this is a name match. Two of the register's current director names also appear among the members the network lists; the register and the page do not say they are the same people, and the network's pages name no officers. The remaining officers are not named here.
- The network's members page lists thirteen named members; the names are on the page and are not repeated here, except for the one with a profile in this project.
- Transgender Map names a "Co-Chair" and others from CAN-SG's own materials; those names are not on the network's own pages, so none is used.
- Its home page links a webinar introducing the network and states no date for it; Transgender Map dates it to 11 October 2023 (see Documented moments). The one event it lists is the conference "Rethinking Youth Gender Medicine" at University College London on 5 and 6 July 2026.
- Companies House officers compared with the letter's signatories: The Companies House officers page for 14935232 (accessed 2026-11-11 and 2026-11-12) lists a director and secretary in the name form "Hakeem, Azeem Maxwell, Dr" (appointed 2023-06-14), a director "Irvine, Marie Louise", and a third director (all appointed 2023-06-14, active; the third director is not named here) and a director "O'Malley, Stella" appointed 2023-06-14 who resigned 2023-07-06. Of the 13 signatories only two could match an entry: Hakeem (already on the page as a name match: the letter says "Dr Az Hakeem", the register says "Azeem Maxwell") and Irvine (the letter says "Dr Louise Irvine", the register says "Marie Louise"). No source reviewed here says either pair is one person, so neither is stated as a director link. The other 11 signatories are not on the officers page. The register's "O'Malley, Stella" director record matches the name of the profiled account stellaomalley3 (Stella O'Malley), whom the network's members page lists as a member; the register gives a name only and no network page says she was a director, so this is a name match on the register and not a stated directorship (she is not a signatory of the letter). The 13 signatories are not shown to be directors or trustees of any profiled body by any source reviewed here.
- The letter of 2025-12-02, signatories: The letter of 2025-12-02 (8, accessed 2026-11-12) is addressed to the chief executive of the Health Research Authority, with the Secretary of State for Health and Social Care as the formal copy; the letter says it is also sent to the MHRA, the NIHR chief executive and the Chief Scientific Officer at the Department of Health and Social Care. It says "we are calling on you to pause the recruitment process" for the PATHWAYS trial; its minimum request is a pause for public post-publication peer review of the protocol. It has 13 signatories, with the titles it prints. The letter names the two co-chairs (Dr Louise Irvine, retired GP; Dr Stella Kingett, consultant adult psychiatrist) and Dr Az Hakeem (consultant adult psychiatrist, medical director of Psyche Clinic, honorary clinical associate professor at UCL Medical School). Sex Matters' page on him (9) calls him "a member of CAN-SG, professional patron of LGB Alliance"; LGB Alliance's own people page (10) lists "Dr Az Hakeem, Patron". The network's about page (7) lists "Dr Az Hakeem MBBS, MSc, FRCPsych", "Consultant Psychiatrist", "Honorary Clinical Associate Professor" and "Medical Forensic Psychotherapist & Group Analyst" under "Some of our members include:" (a partial list of members). The other ten are listed by the title the letter prints, not by name. The ten, by printed title: a registered nurse and clinical researcher; a child and adolescent psychologist "specialising in gender-related distress in children"; a retired psychiatrist and psychoanalyst; a retired consultant breast surgeon and clinical research lead; a GP; a consultant adult psychiatrist; a professor of clinical neuropsychology at UCL Queen Square Institute of Neurology; a consultant paediatrician; a retired consultant paediatrician and former named doctor for child safeguarding; a consultant psychiatrist who is an honorary professor in the UCL Genetics Institute.
Anti-trans work: documented moments
- 2023-06-14: incorporated (Companies House).
- 2024-04-28 (date in the page's address): "Summary of Cass Review" posted on the network's site; 2024-06-28 (date in the address): "Letter to WHO expressing new concerns about influence of WPATH on transgender guideline development"; April 2025: "CAN-SG Letter to Health Research Authority"; December 2025: "Letter to PATHWAYS trial regulators". The letters and the Cass summary are the network's own titles as listed on its site; the letters are given by title only (1). Appeals to the Cass Review are bad-faith anti-trans rhetoric; the evidence brief cites a peer-reviewed BMC Medical Research Methodology appraisal (2025) rating all seven systematic reviews commissioned for Cass at high risk of bias, and a low certainty rating for youth care describes study design in a field where randomized trials are widely considered unethical.
- Other titles on the site: "Ethical Concerns about Puberty Blocker Trials for Children", "Unfinished business following NHS England ban on routine use of puberty blockers" and "What is 'Social Transition' and why is it important?" (1, titles only).
- 5 and 6 July 2026: a conference, "Rethinking Youth Gender Medicine", jointly organised by the network and the Society for Evidence Based Gender Medicine (SEGM; profiled): 11 says it was "jointly organised by the Clinical Advisory Network on Sex and Gender and the Society for Evidence Based Gender Medicine" and places it in Central London, a ticket listing gives the dates 5-6 July 2026, and the network's own page (1) places it at University College London and says the conference "was a great success" (the two pages give different venues; each is stated with its source).
- Sex Matters lists the network under "Sector networks" and describes it as a "Group of clinicians" concerned about "established medical bodies' and regulators' uncritical support for experimental treatments", and "calls upon healthcare organisations to develop evidence-based policies for data collection and single-sex spaces" (12, accessed 2026-11-11). The listing states no tie between Sex Matters and the network.
- Transgender Map, an advocacy site, dates a webinar, "Introducing the Clinical Advisory Network on Sex & Gender", to 11 October 2023 with four named speakers, one of them the profiled psychotherapist (13; the date is the site's, not confirmed by the network).
- The network's briefings page lists more than two letters; two are described here (1): 2025-04-07, to the chief executive of the Health Research Authority, written "on behalf of" the network, "a network of over 100 health professionals" (the network's members page names thirteen members and the December letter has thirteen signatories), which says "We believe that the proposed trial is unethical" and asks to meet the Authority (14); and 2025-12-02, to the Authority's chief executive, also sent to the MHRA, the NIHR chief executive and the Department of Health and Social Care's chief scientific officer and copied to the Health Secretary, which says "We are making an Appeal against the Approval you gave the Trial" and asks "at the very least" for recruitment to be paused (8). The letters are anti-trans rhetoric against a trial of the puberty blockers the evidence brief documents as reversible care with rare serious harm; the April letter's wording about "recruiting healthy children to a trial" and the appeal to ethics are the same shield the rest of this campaign uses, and the High Court rejected the related challenge on 2026-07-31 (judgment read, see the Bayswater page).
Evidence that the protective framing is a pretext
No evidence of an adult limit is documented for this body; the campaign is anti-trans rhetoric made in bad faith whatever its protective framing. The network's pages read are about care for young people and about data and single-sex spaces; none states a position on adults, and no source reviewed here ties the network to an adult limit. The framing of "treatments" as "experimental" is the same used to oppose care at every age by others in this project, but that is alignment, not evidence about this body.
Ties
- Not a tie: a register director of the same name as a profiled psychotherapist (2023-06-14 to 2023-07-06; name match; listed as hers by Transgender Map only), and a member of that name on the network's own page (narrative alignment only; name match).
- Formal joint work: the Society for Evidence Based Gender Medicine (SEGM; profiled) and the network jointly organised the "Rethinking Youth Gender Medicine" conference of 5 and 6 July 2026, as SEGM's own page states (11). The network's home page also names SEGM in the same paragraph and links to it.
- Narrative alignment only (not a tie): its December 2025 letter to the regulators of the PATHWAYS trial concerns the trial that Bayswater Support Group, Keira Bell and James Esses challenged in the High Court (see the JamesEsses profile); no source reviewed here connects the network to that claim. A register director's name matches an advisory-board name on Transgender Map's list for the Gender Exploratory Therapy Association; that is a name match, and the network's members page lists that name as a member, not a director.
Open questions
- The company's income and expenditure (the micro-entity accounts file no income statement) and any registered persons with significant control.
- Whether the officers named in the register are the members the network lists under the same names: the December 2025 letter names two co-chairs (see People on file); a signatory line is not a statement that anyone is a company director. The 13 signatories are not shown to be directors or trustees of any profiled body by any source reviewed here; two of them, Hakeem and Irvine, match register names only in part and neither pair is stated to be one person.
- The date of the launch event: the network's pages state no launch date; Transgender Map dates the introductory webinar to 11 October 2023, a date the network does not confirm. The letters of April 2025 and December 2025 are described under the documented moments.
Information packet: the full written profile, every claim, table and source, to read, print or save as PDF.
Sources
- https://can-sg.org
- https://find-and-update.company-information.service.gov.uk/company/14935232
- https://register-of-charities.charitycommission.gov.uk/
- https://www.charitycommissionni.org.uk/charity-search/
- https://www.oscr.org.uk/about-charities/search-the-register/
- https://can-sg.org/about-us
- https://can-sg.org/about-us/
- https://can-sg.org/letter-to-pathways-trial-regulators-december-2025/
- https://sex-matters.org/?p=162944
- https://lgballiance.org.uk/people/
- https://segm.org/London-2026
- https://sex-matters.org/posts/healthcare/can-sg/
- https://www.transgendermap.com/issues/regret/clinical-advisory-network-on-sex-and-gender/
- https://can-sg.org/can-sg-letter-to-health-research-authority-april-2025/